Latest filing published 09 Apr 2026 for HOLOGIC INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Stephen P. Macmillan across 3 companies, led by Hologic Inc, Boston Scientific Corp and Illumina, Inc. Between 5 November 2016 and 7 April 2026, the trades on record add up to 85 filings.
Sales make up the whole of the open-market record (7 sales, €36.4M). Outside the open market, there are 46 share grants and 22 option exercises.
The newest entry dates from 9 April 2026: a transaction, in Hologic Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations